Article
Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants.
Biochemical pharmacology - 15 Aug 2008
Ahlstedt Ingela, Engberg Susanna, Smith John, Perrey Chris, Moody Adrian, Morten John, Lagerström-Fermér Maria, Drmota Tomas, von Mentzer Bengt, Påhlman Ingrid, Lindström Erik
Abstract excerpt
Tachykinin NK(2) receptor antagonists are potentially beneficial in treating various disorders including irritable bowel syndrome, urinary incontinence, depression and anxiety. The current study evaluates the frequency of single nucleotide polymorphisms (SNPs) in the human NK(2) receptor gene (TACR2). In addition, the potency of the endogenous peptide agonist neurokinin A (NKA), and the small molecule antagonists...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
